These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2716926)

  • 1. Alpha-2b interferon in the treatment of advanced chronic lymphocytic leukemia.
    Klener P; Háber J; Hausner P
    Neoplasma; 1989; 36(2):215-20. PubMed ID: 2716926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease.
    Molica S; Alberti A
    Haematologica; 1990; 75(1):75-8. PubMed ID: 2338291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy.
    O'Brien S; Kantarjian H; Beran M; Robertson LE; Koller C; Lerner S; Keating MJ
    Blood; 1995 Aug; 86(4):1298-300. PubMed ID: 7632936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia.
    Koníková E; Babusíková O; Mesárosová A; Kusenda J; Glasová M
    Neoplasma; 1994; 41(2):69-74. PubMed ID: 8208317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose "natural" alpha-interferon in B-cell derived chronic lymphocytic leukemia.
    Pozzato G; Franzin F; Moretti M; Tulissi P; Pecorari P; Melato M; Zacchi T; Evangelisti P; Campanacci L
    Haematologica; 1992; 77(5):413-7. PubMed ID: 1483591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
    Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
    Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
    Mauro FR; Zinzani P; Zaja F; Gentile M; Vegna ML; Stefoni V; Marin L; Fanin R; Baccarani M; Tura S; Mandelli F
    Haematologica; 2003 Dec; 88(12):1348-57. PubMed ID: 14687987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
    Zinzani PL; Levrero MG; Lauria F; Rondelli D; Zaja F; Russo D; Fanin R; De Rossi G; Mauro FR; Bendandi M; Gozzetti A; Dianzani F; Mandelli F; Tura S
    Haematologica; 1994; 79(1):55-60. PubMed ID: 15378949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
    Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
    Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
    Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia.
    Barcellini W; Capalbo S; Agostinelli RM; Mauro FR; Ambrosetti A; Calori R; Cortelezzi A; Laurenti L; Pogliani EM; Pedotti P; Liso V; Girelli G; Mandelli F; Zanella A;
    Haematologica; 2006 Dec; 91(12):1689-92. PubMed ID: 17145607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of recombinant interferon levels by high performance immunoaffinity chromatography in body fluids of cancer patients on interferon therapy.
    Phillips TM
    Biomed Chromatogr; 1992; 6(6):287-90. PubMed ID: 1286286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.